0.0050
+0.0010
+(25.00%)
At close: 3:36:39 PM GMT+10
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-5,506.1130
-7,537.7240
-16,305.7530
-13,129.7750
-8,835.3750
Investing Cash Flow
2.5150
--
-112.1930
-564.8780
-5,304.3920
Financing Cash Flow
6,976.0050
8,256.7590
253.3760
9,503.6780
36,541.3630
End Cash Position
4,997.8100
3,053.0010
2,362.6540
18,381.5330
22,410.1990
Capital Expenditure
-537.8550
--
-112.1930
-537.8550
-5,307.0380
Issuance of Capital Stock
9,172.0660
11,740.2530
2,577.4970
14,898.9110
39,300
Issuance of Debt
--
--
--
--
858.0240
Repayment of Debt
-4,086.5690
-2,277
-2,225
-4,086.5690
-892.0310
Repurchase of Capital Stock
-732.9690
-1,196.3810
-88.8190
-1,308.6640
-2,715.0490
Free Cash Flow
-5,506.1130
-7,537.7240
-16,417.9460
-13,667.6300
-14,142.4130
6/30/2021 - 1/17/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0350
0.00%
VBS.AX Vectus Biosystems Limited
0.0800
0.00%
IXC.AX Invex Therapeutics Ltd
0.0700
0.00%
BTC.AX BTC Health Limited
0.0460
-8.00%
1AI.AX Algorae Pharmaceuticals Limited
0.0060
+20.00%
RNV.AX RENERVE FPO [RNV]
0.1100
+4.76%
ANR.AX Anatara Lifesciences Ltd
0.0060
0.00%
TRP.AX Tissue Repair Ltd
0.2400
0.00%
BGT.AX Bio-Gene Technology Limited
0.0310
0.00%
CMB.AX Cambium Bio Limited
0.3000
+7.14%